These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22419069)

  • 1. Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediatric embryonal and alveolar rhabdomyosarcomas.
    Mahoney SE; Yao Z; Keyes CC; Tapscott SJ; Diede SJ
    Epigenetics; 2012 Apr; 7(4):400-8. PubMed ID: 22419069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upstream CpG island methylation of the PAX3 gene in human rhabdomyosarcomas.
    Kurmasheva RT; Peterson CA; Parham DM; Chen B; McDonald RE; Cooney CA
    Pediatr Blood Cancer; 2005 Apr; 44(4):328-37. PubMed ID: 15602708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NELL1, whose high expression correlates with negative outcomes, has different methylation patterns in alveolar and embryonal rhabdomyosarcoma.
    Tombolan L; Poli E; Martini P; Zin A; Romualdi C; Bisogno G; Lanfranchi G
    Oncotarget; 2017 May; 8(20):33086-33099. PubMed ID: 28380437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O6-methylguanine-DNA methyltransferase activity and promoter methylation status in pediatric rhabdomyosarcoma.
    Yeager ND; Dolan ME; Gastier JM; Gross TG; Delaney S; Frick J; Ruymann FB; Ewesuedo R
    J Pediatr Hematol Oncol; 2003 Dec; 25(12):941-7. PubMed ID: 14663276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation alterations of the MyoD1 upstream region are predictive of subclassification of human rhabdomyosarcomas.
    Chen B; Dias P; Jenkins JJ; Savell VH; Parham DM
    Am J Pathol; 1998 Apr; 152(4):1071-9. PubMed ID: 9546368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.
    De Salvo M; Raimondi L; Vella S; Adesso L; Ciarapica R; Verginelli F; Pannuti A; Citti A; Boldrini R; Milano GM; Cacchione A; Ferrari A; Collini P; Rosolen A; Bisogno G; Alaggio R; Inserra A; Locatelli M; Stifani S; Screpanti I; Miele L; Locatelli F; Rota R
    PLoS One; 2014; 9(5):e96238. PubMed ID: 24797362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of invasion promoting genes in childhood rhabdomyosarcoma.
    Armeanu-Ebinger S; Bonin M; Häbig K; Poremba C; Koscielniak E; Godzinski J; Warmann SW; Fuchs J; Seitz G
    Int J Oncol; 2011 Apr; 38(4):993-1000. PubMed ID: 21271214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma.
    Ganti R; Skapek SX; Zhang J; Fuller CE; Wu J; Billups CA; Breitfeld PP; Dalton JD; Meyer WH; Khoury JD
    Mod Pathol; 2006 Sep; 19(9):1213-20. PubMed ID: 16729016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-catenin mutation does not seem to have an effect on the tumorigenesis of pediatric rhabdomyosarcomas.
    Bouron-Dal Soglio D; Rougemont AL; Absi R; Giroux LM; Sanchez R; Barrette S; Fournet JC
    Pediatr Dev Pathol; 2009; 12(5):371-3. PubMed ID: 19222307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.
    Seki M; Nishimura R; Yoshida K; Shimamura T; Shiraishi Y; Sato Y; Kato M; Chiba K; Tanaka H; Hoshino N; Nagae G; Shiozawa Y; Okuno Y; Hosoi H; Tanaka Y; Okita H; Miyachi M; Souzaki R; Taguchi T; Koh K; Hanada R; Kato K; Nomura Y; Akiyama M; Oka A; Igarashi T; Miyano S; Aburatani H; Hayashi Y; Ogawa S; Takita J
    Nat Commun; 2015 Jul; 6():7557. PubMed ID: 26138366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
    Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of Snail1 transcription factor and Snail1-related genes in alveolar and embryonal rhabdomyosarcoma subtypes.
    Püsküllüoglu M; Lukasiewicz E; Miekus K; Jarocha D; Majka M
    Folia Histochem Cytobiol; 2010 Dec; 48(4):671-7. PubMed ID: 21478114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXO1a acts as a selective tumor suppressor in alveolar rhabdomyosarcoma.
    Bois PR; Izeradjene K; Houghton PJ; Cleveland JL; Houghton JA; Grosveld GC
    J Cell Biol; 2005 Sep; 170(6):903-12. PubMed ID: 16157701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cytogenetic analysis consistently identifies translocations involving chromosomes 1, 2 and 15 in five embryonal rhabdomyosarcoma cell lines and a PAX-FOXO1A fusion gene negative alveolar rhabdomyosarcoma cell line.
    Roberts I; Gordon A; Wang R; Pritchard-Jones K; Shipley J; Coleman N
    Cytogenet Cell Genet; 2001; 95(3-4):134-42. PubMed ID: 12063389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.
    Tombolan L; Poli E; Martini P; Zin A; Millino C; Pacchioni B; Celegato B; Bisogno G; Romualdi C; Rosolen A; Lanfranchi G
    BMC Cancer; 2016 Nov; 16(1):886. PubMed ID: 27842508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes.
    Bridge JA; Liu J; Qualman SJ; Suijkerbuijk R; Wenger G; Zhang J; Wan X; Baker KS; Sorensen P; Barr FG
    Genes Chromosomes Cancer; 2002 Mar; 33(3):310-21. PubMed ID: 11807989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alveolar rhabdomyosarcoma: a prognostically unfavorable rhabdomyosarcoma type and its necessary distinction from embryonal rhabdomyosarcoma.
    Harms D
    Curr Top Pathol; 1995; 89():273-96. PubMed ID: 7882714
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of Wnt/β-catenin signaling in rhabdomyosarcoma.
    Annavarapu SR; Cialfi S; Dominici C; Kokai GK; Uccini S; Ceccarelli S; McDowell HP; Helliwell TR
    Lab Invest; 2013 Oct; 93(10):1090-9. PubMed ID: 23999248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes on chromosome 11p15.5 as specific marker for embryonal rhabdomyosarcoma?
    Vicha A; Jencova P; Novakova-Kodetova D; Stolova L; Voriskova D; Vyletalova K; Broz P; Drahokoupilova E; Guha A; Kopecká M; Krskova L
    Genes Chromosomes Cancer; 2023 Dec; 62(12):732-739. PubMed ID: 37530573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Roles for Staufen1 in Embryonal and Alveolar Rhabdomyosarcoma via c-myc-dependent and -independent events.
    Crawford Parks TE; Marcellus KA; Langill J; Ravel-Chapuis A; Michaud J; Cowan KN; Côté J; Jasmin BJ
    Sci Rep; 2017 Feb; 7():42342. PubMed ID: 28211476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.